| Filed | 
                                    Name | 
                                     | 
                                    Company | 
                                    Pur. £ | 
                                    Cur. £ | 
                                    P/L % | 
                                    MPV* | 
                                
                                
                                
                                                                                                                
                                                | 
                                                    Apr '12
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Glendonbrook
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Astrazeneca / LSE:AZN.L                                                  | 
                                                
                                                    £2,666.50
                                                 | 
                                                
                                                    £12,546.00
                                                 | 
                                                                                                                                                                                                                
                                                    370.50%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £329,353.08
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Apr '10
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Baroness Noakes
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Astrazeneca / LSE:AZN.L                                                  | 
                                                
                                                    £2,938.00
                                                 | 
                                                
                                                    £12,546.00
                                                 | 
                                                                                                                                                                                                                
                                                    327.03%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £298,917.63
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Mar '14
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Viscount Eccles
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Astrazeneca / LSE:AZN.L                                                  | 
                                                
                                                    £3,876.50
                                                 | 
                                                
                                                    £12,546.00
                                                 | 
                                                                                                                                                                                                                
                                                    223.64%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £226,549.72
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Feb '11
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Wasserman
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Johnson & Johnson / NYQ:JNJ                                                  | 
                                                
                                                    £60.93
                                                 | 
                                                
                                                    £189.05
                                                 | 
                                                                                                                                                                                                                
                                                    210.27%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £217,191.86
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Dec '16
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Burns
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Astrazeneca / LSE:AZN.L                                                  | 
                                                
                                                    £4,116.00
                                                 | 
                                                
                                                    £12,546.00
                                                 | 
                                                                                                                                                                                                                
                                                    204.81%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £213,367.35
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Jan '13
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Sassoon
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Johnson & Johnson / NYQ:JNJ                                                  | 
                                                
                                                    £72.69
                                                 | 
                                                
                                                    £189.05
                                                 | 
                                                                                                                                                                                                                
                                                    160.08%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £182,053.93
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    May '18
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Grabiner
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Astrazeneca / LSE:AZN.L                                                  | 
                                                
                                                    £5,417.00
                                                 | 
                                                
                                                    £12,546.00
                                                 | 
                                                                                                                                                                                                                
                                                    131.60%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £162,122.95
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    May '11
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Glendonbrook
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Novartis / NYQ:NVS                                                  | 
                                                
                                                    £54.04
                                                 | 
                                                
                                                    £122.61
                                                 | 
                                                                                                                                                                                                                
                                                    126.88%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £158,817.66
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Sep '16
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Gadhia
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Astrazeneca / LSE:AZN.L                                                  | 
                                                
                                                    £5,099.00
                                                 | 
                                                
                                                    £10,024.00
                                                 | 
                                                                                                                                                                                                                
                                                    96.59%
                                                 | 
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                        £137,611.30**
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Apr '17
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Donoughue
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Novartis / NYQ:NVS                                                  | 
                                                
                                                    £66.05
                                                 | 
                                                
                                                    £122.61
                                                 | 
                                                                                                                                                                                                                
                                                    85.64%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £129,945.64
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Feb '21
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Etherton
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Astrazeneca / LSE:AZN.L                                                  | 
                                                
                                                    £7,422.00
                                                 | 
                                                
                                                    £12,546.00
                                                 | 
                                                                                                                                                                                                                
                                                    69.04%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £118,326.60
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Aug '14
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Carter of Coles
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Johnson & Johnson / NYQ:JNJ                                                  | 
                                                
                                                    £100.16
                                                 | 
                                                
                                                    £161.55
                                                 | 
                                                                                                                                                                                                                
                                                    61.29%
                                                 | 
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                        £112,904.35**
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Jun '21
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Morse
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Astrazeneca / LSE:AZN.L                                                  | 
                                                
                                                    £8,005.00
                                                 | 
                                                
                                                    £12,546.00
                                                 | 
                                                                                                                                                                                                                
                                                    56.73%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £109,708.93
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Jul '16
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Lloyd-Webber
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Johnson & Johnson / NYQ:JNJ                                                  | 
                                                
                                                    £122.64
                                                 | 
                                                
                                                    £189.05
                                                 | 
                                                                                                                                                                                                                
                                                    54.15%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £107,905.25
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    May '24
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Goldsmith
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Abbvie / NYQ:ABBV                                                  | 
                                                
                                                    £160.81
                                                 | 
                                                
                                                    £228.20
                                                 | 
                                                                                                                                                                                                                
                                                    41.91%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £99,334.62
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Apr '21
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Baroness Deech
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Novartis / NYQ:NVS                                                  | 
                                                
                                                    £88.38
                                                 | 
                                                
                                                    £122.61
                                                 | 
                                                                                                                                                                                                                
                                                    38.73%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £97,111.34
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    May '20
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Deighton
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Astrazeneca / LSE:AZN.L                                                  | 
                                                
                                                    £8,361.00
                                                 | 
                                                
                                                    £11,236.00
                                                 | 
                                                                                                                                                                                                                
                                                    34.39%
                                                 | 
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                        £94,070.09**
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Nov '23
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Mance
                                                 | 
                                                                                                     | 
                                                                                                
                                                    Eli Lilly Co / VIE:LLYC.VI                                                  | 
                                                
                                                    £557.00
                                                 | 
                                                
                                                    £732.20
                                                 | 
                                                                                                                                                                                                                
                                                    31.45%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £92,017.95
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    May '25
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Hayward
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Glaxosmithkline / NYQ:GSK                                                  | 
                                                
                                                    £37.37
                                                 | 
                                                
                                                    £46.94
                                                 | 
                                                                                                                                                                                                                
                                                    25.61%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £87,926.14
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Dec '16
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Burns
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Glaxosmithkline / NYQ:GSK                                                  | 
                                                
                                                    £37.39
                                                 | 
                                                
                                                    £46.94
                                                 | 
                                                                                                                                                                                                                
                                                    25.54%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £87,879.11
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    May '11
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Glendonbrook
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Pfizer / NYQ:PFE                                                  | 
                                                
                                                    £19.54
                                                 | 
                                                
                                                    £24.29
                                                 | 
                                                                                                                                                                                                                
                                                    24.28%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £86,995.94
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Nov '23
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Mance
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Astrazeneca / LSE:AZN.L                                                  | 
                                                
                                                    £10,230.00
                                                 | 
                                                
                                                    £12,546.00
                                                 | 
                                                                                                                                                                                                                
                                                    22.64%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £85,847.51
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Apr '10
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Levene of Portsoken
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Glaxosmithkline / NYQ:GSK                                                  | 
                                                
                                                    £39.38
                                                 | 
                                                
                                                    £46.94
                                                 | 
                                                                                                                                                                                                                
                                                    19.20%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £83,438.29
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Apr '10
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Baroness Noakes
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Glaxosmithkline / NYQ:GSK                                                  | 
                                                
                                                    £39.49
                                                 | 
                                                
                                                    £46.94
                                                 | 
                                                                                                                                                                                                                
                                                    18.87%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £83,205.87
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Aug '17
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Sterling of Plaistow
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Johnson & Johnson / NYQ:JNJ                                                  | 
                                                
                                                    £133.45
                                                 | 
                                                
                                                    £157.98
                                                 | 
                                                                                                                                                                                                                
                                                    18.38%
                                                 | 
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                        £82,866.99**
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Mar '25
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Fink
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Johnson & Johnson / NYQ:JNJ                                                  | 
                                                
                                                    £161.72
                                                 | 
                                                
                                                    £189.05
                                                 | 
                                                                                                                                                                                                                
                                                    16.90%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £81,829.71
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Apr '24
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Mendoza
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Eli Lilly / NYQ:LLY                                                  | 
                                                
                                                    £731.33
                                                 | 
                                                
                                                    £844.50
                                                 | 
                                                                                                                                                                                                                
                                                    15.47%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £80,832.18
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    May '23
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Fink
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Johnson & Johnson / NYQ:JNJ                                                  | 
                                                
                                                    £165.03
                                                 | 
                                                
                                                    £189.05
                                                 | 
                                                                                                                                                                                                                
                                                    14.55%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £80,188.45
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Apr '23
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Grabiner
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Novartis / NYQ:NVS                                                  | 
                                                
                                                    £95.80
                                                 | 
                                                
                                                    £107.52
                                                 | 
                                                                                                                                                                                                                
                                                    12.23%
                                                 | 
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                        £78,563.67**
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Apr '21
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Farmer
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Glaxosmithkline / NYQ:GSK                                                  | 
                                                
                                                    £36.65
                                                 | 
                                                
                                                    £40.88
                                                 | 
                                                                                                                                                                                                                
                                                    11.54%
                                                 | 
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                        £78,079.12**
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Mar '17
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Lloyd-Webber
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Glaxosmithkline / NYQ:GSK                                                  | 
                                                
                                                    £42.31
                                                 | 
                                                
                                                    £46.94
                                                 | 
                                                                                                                                                                                                                
                                                    10.94%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £77,660.12
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    May '11
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Glendonbrook
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Glaxosmithkline / NYQ:GSK                                                  | 
                                                
                                                    £42.78
                                                 | 
                                                
                                                    £46.94
                                                 | 
                                                                                                                                                                                                                
                                                    9.72%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £76,806.92
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Oct '20
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Taverne
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Glaxosmithkline / NYQ:GSK                                                  | 
                                                
                                                    £37.57
                                                 | 
                                                
                                                    £40.95
                                                 | 
                                                                                                                                                                                                                
                                                    9.00%
                                                 | 
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                        £76,297.58**
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    May '24
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Balfe
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Glaxosmithkline / NYQ:GSK                                                  | 
                                                
                                                    £44.02
                                                 | 
                                                
                                                    £46.94
                                                 | 
                                                                                                                                                                                                                
                                                    6.63%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £74,643.34
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    May '23
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Fink
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Astrazeneca / LSE:AZN.L                                                  | 
                                                
                                                    £11,774.00
                                                 | 
                                                
                                                    £12,546.00
                                                 | 
                                                                                                                                                                                                                
                                                    6.56%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £74,589.77
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    May '23
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Londesborough
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Astrazeneca / LSE:AZN.L                                                  | 
                                                
                                                    £11,924.00
                                                 | 
                                                
                                                    £12,546.00
                                                 | 
                                                                                                                                                                                                                
                                                    5.22%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £73,651.46
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Jan '13
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Sassoon
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Glaxosmithkline / NYQ:GSK                                                  | 
                                                
                                                    £44.75
                                                 | 
                                                
                                                    £46.94
                                                 | 
                                                                                                                                                                                                                
                                                    4.89%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £73,425.70
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    May '23
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Leitch
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Astrazeneca / LSE:AZN.L                                                  | 
                                                
                                                    £11,820.00
                                                 | 
                                                
                                                    £12,340.00
                                                 | 
                                                                                                                                                                                                                
                                                    4.40%
                                                 | 
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                        £73,079.53**
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Apr '24
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Balfe
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Astrazeneca / LSE:AZN.L                                                  | 
                                                
                                                    £12,024.00
                                                 | 
                                                
                                                    £12,546.00
                                                 | 
                                                                                                                                                                                                                
                                                    4.34%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £73,038.92
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Jan '24
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Fink
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Roche / EBS:ROG.SW                                                  | 
                                                
                                                    £251.85
                                                 | 
                                                
                                                    £261.70
                                                 | 
                                                                                                                                                                                                                
                                                    3.91%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £72,737.74
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    May '24
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Goldsmith
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Astrazeneca / LSE:AZN.L                                                  | 
                                                
                                                    £12,156.00
                                                 | 
                                                
                                                    £12,546.00
                                                 | 
                                                                                                                                                                                                                
                                                    3.21%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £72,245.80
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Apr '17
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Leigh of Hurley
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Roche / EBS:ROG.SW                                                  | 
                                                
                                                    £255.80
                                                 | 
                                                
                                                    £261.70
                                                 | 
                                                                                                                                                                                                                
                                                    2.31%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £71,614.55
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Feb '25
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Green of Hurstpierpoint
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Roche / EBS:ROG.SW                                                  | 
                                                
                                                    £285.70
                                                 | 
                                                
                                                    £272.40
                                                 | 
                                                                                                                                                                                                                
                                                    -4.66%
                                                 | 
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                        £66,741.33**
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Jan '20
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Gadhia
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Glaxosmithkline / NYQ:GSK                                                  | 
                                                
                                                    £46.50
                                                 | 
                                                
                                                    £40.95
                                                 | 
                                                                                                                                                                                                                
                                                    -11.94%
                                                 | 
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                        £61,645.16**
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Mar '14
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Baroness Eccles of Moulton
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Glaxosmithkline / NYQ:GSK                                                  | 
                                                
                                                    £53.43
                                                 | 
                                                
                                                    £46.94
                                                 | 
                                                                                                                                                                                                                
                                                    -12.15%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £61,497.28
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Mar '25
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Fink
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Roche / EBS:ROG.SW                                                  | 
                                                
                                                    £303.00
                                                 | 
                                                
                                                    £261.70
                                                 | 
                                                                                                                                                                                                                
                                                    -13.63%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £60,458.75
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Apr '22
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Cromwell
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Johnson & Johnson / NYQ:JNJ                                                  | 
                                                
                                                    £179.90
                                                 | 
                                                
                                                    £154.37
                                                 | 
                                                                                                                                                                                                                
                                                    -14.19%
                                                 | 
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                        £60,066.15**
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    May '23
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Reay
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Sanofi / NMS:SNY                                                  | 
                                                
                                                    £55.11
                                                 | 
                                                
                                                    £47.22
                                                 | 
                                                                                                                                                                                                                
                                                    -14.32%
                                                 | 
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                        £59,978.23**
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Apr '21
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Grabiner
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Roche / EBS:ROG.SW                                                  | 
                                                
                                                    £309.65
                                                 | 
                                                
                                                    £261.70
                                                 | 
                                                                                                                                                                                                                
                                                    -15.49%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £59,160.35
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Feb '16
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Lloyd-Webber
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Pfizer / NYQ:PFE                                                  | 
                                                
                                                    £29.02
                                                 | 
                                                
                                                    £24.29
                                                 | 
                                                                                                                                                                                                                
                                                    -16.31%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £58,585.04
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Aug '16
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Lloyd-Webber
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Eli Lilly / NYQ:LLY                                                  | 
                                                
                                                    £80.55
                                                 | 
                                                
                                                    £67.15
                                                 | 
                                                                                                                                                                                                                
                                                    -16.64%
                                                 | 
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                        £58,355.06**
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Aug '20
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Reay
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Roche / EBS:ROG.SW                                                  | 
                                                
                                                    £315.05
                                                 | 
                                                
                                                    £249.80
                                                 | 
                                                                                                                                                                                                                
                                                    -20.71%
                                                 | 
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                        £55,502.30**
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Jul '18
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Glendonbrook
                                                 | 
                                                                                                     | 
                                                                                                
                                                    Bayer / GER:BAYN.DE                                                  | 
                                                
                                                    £95.26
                                                 | 
                                                
                                                    £26.87
                                                 | 
                                                                                                                                                                                                                
                                                    -71.79%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £19,744.91
                                                    
                                                 | 
                                            
                                                                                                    
                            
                            * Minimum Potential Value based on £70,000.00 invested at time of declaration.
                            ** Interest ceased/exited on filed date.